Invention Grant
- Patent Title: 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
-
Application No.: US16835938Application Date: 2020-03-31
-
Publication No.: US11053218B2Publication Date: 2021-07-06
- Inventor: Rohan Eric John Beckwith , Simone Bonazzi , Artiom Cernijenko , Aleem Fazal , Ritesh Bhanudasji Tichkule , Michael Scott Visser
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/4412 ; C07D401/04 ; C07D407/14 ; C07D409/14 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; C07D487/08 ; C07D495/04 ; C07D513/04 ; A61P35/00
Abstract:
The present disclosure provides a compound of Formula (I′): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R1, R2, Rx, X1, n, n1, and q are as defined herein, and methods of making and using same.
Public/Granted literature
- US20200231569A1 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Public/Granted day:2020-07-23
Information query
